Selected article for: "long covid and lung infection"
Author: Vitiello, Antonio; Ferrara, Francesco
Title: Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
  • Cord-id: dfkoso7t
  • Document date: 2021_9_16
    • ID: dfkoso7t
    Snippet: The COVID-19 global pandemic has caused about 4,30 Mln deaths. Recently the first vaccines have been licensed, representing the most powerful weapon available to stop the pandemic. The COVID-19 viral infection in the most severe cases can cause severe lung lesions with the presence of fibrotic tissue. Even among cured individuals, the presence of pulmonary fibrotic tissue may be the major cause of long-term complications of COVID-19 requiring antifibrotic therapeutic treatment even in the post-
    Document: The COVID-19 global pandemic has caused about 4,30 Mln deaths. Recently the first vaccines have been licensed, representing the most powerful weapon available to stop the pandemic. The COVID-19 viral infection in the most severe cases can cause severe lung lesions with the presence of fibrotic tissue. Even among cured individuals, the presence of pulmonary fibrotic tissue may be the major cause of long-term complications of COVID-19 requiring antifibrotic therapeutic treatment even in the post-COVID-19 infection phase to accelerate the healing process and fully recover lung function. This article reviews the fibrogenic mechanism of SARS-CoV-2-induced viral damage and the antifibrotic treatments indicated to treat sequelae post COVID-19 infection.

    Search related documents:
    Co phrase search for related documents
    • abundant presence and acute phase: 1
    • abundant presence and acute sars respiratory syndrome: 1, 2, 3, 4
    • abundant presence and liver heart: 1
    • ace dependent and acute infection: 1
    • ace dependent and acute sars respiratory syndrome: 1, 2
    • ace dependent and liver heart: 1
    • ace dependent pathway and liver heart: 1
    • action anti and acute infection: 1, 2, 3, 4, 5, 6, 7, 8
    • action anti and acute phase: 1, 2, 3, 4
    • action anti and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • activate immune system and acute infection: 1, 2
    • activate immune system and acute phase: 1
    • activate immune system and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • acute infection and liver heart: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute phase and liver heart: 1, 2, 3, 4, 5, 6